TOP STORIES

• REGULATORY Japan Approves Jardiance for Heart Failure, Label Expansions for Opdivo and Keytruda
  November 26, 2021

• REGULATORY Pharma Pushes 2% Adjustment Rate Plus Certain Range in 2022 Drug Price Revision
  November 26, 2021

• REGULATORY Sanofi’s Praluent to Be Taken Off Japan NHI Price List Next Spring
  November 26, 2021

• REGULATORY LDP Health Panel Chief Vows to Push Development of Japan-Made Vaccines and Drugs
  November 25, 2021

• BUSINESS Top 3 Japan Generic Makers Face Uphill Struggle Overseas in April-September: Jiho Tally
  November 25, 2021

• BUSINESS Japan Biz of Top 3 Generic Makers in H1 Impacted by GMP Issues, Substitution Demand: Jiho Tally
  November 25, 2021

• BUSINESS Alnylam to File Its Third Drug in Japan 3 Years after Market Entry, Eyes CNS Therapies
  November 24, 2021

• ORGANIZATION 20% of Listed Drugs in Japan, Mostly Generics, Hit by Supply Issues: FPMAJ Survey
  November 22, 2021

• REGULATORY Japan OKs 56 Trillion Yen Stimulus Package, Spells Out Support for Japan-Made Drugs and Vaccines
  November 22, 2021

• BUSINESS Top 4 Wholesalers’ Average Operating Margin at 0.46% on Tough Price Negotiations: H1 FY2021 Earnings
  November 22, 2021

• REGULATORY Japan Panel Discusses Safety, Immunity Rules for Envisaged Emergency Approval Scheme
  November 19, 2021

• REGULATORY Ex-Minister Tamura Says Efficacy/Safety Confirmation Important in Emergency Approval, Wary on Macroeconomic Indexing
  November 18, 2021

• BUSINESS Otsuka’s Eczema Drug, 2 More Products Skip November Listing
  November 18, 2021

• BUSINESS Aducanumab Gets “Negative Trend Vote” in Europe: Biogen/Eisai
  November 18, 2021

• REGULATORY 50 Billion Yen-Plus Peak Sales Projected for Pfizer’s Vynmac, Listing Set for Nov. 25
  November 17, 2021

• COMMENTARY MOF, MHLW Push Conflicting Narratives on Drug Cost Control; Macroeconomic Indexing Is a Major Focus Too
  November 16, 2021

• REGULATORY Japan to Use mRNA Jabs for Boosters, Pfizer Vaccine for Time Being: Panel
  November 16, 2021

• BUSINESS Ono to Pay 28 Billion Yen to Settle Opdivo Feud with Honjo
  November 15, 2021

• REGULATORY Govt to Provide Up to 2 Billion Yen per Oral COVID-19 Drug to Support Development
  November 15, 2021

• BUSINESS Aikomi, Sumitomo Dainippon Eye Therapeutic App Approval for BPSD by 2027
  November 12, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 77
• 78
• 79
• 80
• 81
• 82
• 83
• 84
• 85
• …
• Next ›
• 最終 »